| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30013303 | HIV | ENSG00000132356.12 | protein_coding | PRKAA1 | No | No | 5562 | Q13131 |
| TVIS30062198 | HIV | ENSG00000132356.12 | protein_coding | PRKAA1 | No | No | 5562 | Q13131 |
| TVIS44012745 | HTLV-1 | ENSG00000132356.12 | protein_coding | PRKAA1 | No | No | 5562 | Q13131 |
| TVIS44050461 | HTLV-1 | ENSG00000132356.12 | protein_coding | PRKAA1 | No | No | 5562 | Q13131 |
| TVIS44050462 | HTLV-1 | ENSG00000132356.12 | protein_coding | PRKAA1 | No | No | 5562 | Q13131 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PRKAA1 |
|---|---|
| DrugBank ID | DB00131 |
| Drug Name | Adenosine phosphate |
| Target ID | BE0004907 |
| UniProt ID | Q9UGI9 |
| Regulation Type | activator |
| PubMed IDs | 28146060 |
| Citations | Marin-Aguilar F, Pavillard LE, Giampieri F, Bullon P, Cordero MD: Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds. Int J Mol Sci. 2017 Jan 29;18(2). pii: ijms18020288. doi: 10.3390/ijms18020288. |
| Groups | Approved; Investigational; Nutraceutical; Withdrawn |
| Direct Classification | Purine ribonucleoside monophosphates |
| SMILES | NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1 |
| Pathways | Leigh Syndrome; Histidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Fatty Acid Metabolism; Gentamicin Action Pathway; Pyruvate Dehydrogenase Complex Deficiency; Purine Nucleoside Phosphorylase Deficiency; Hyperprolinemia Type II; Glutamate Metabolism; Clarithromycin Action Pathway; Argininosuccinic Aciduria; Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency); Hyperinsulinism-Hyperammonemia Syndrome; Butyrate Metabolism; Pyruvate Metabolism; Pentose Phosphate Pathway; Propanoate Metabolism; Glycine and Serine Metabolism; Selenoamino Acid Metabolism; Thiamine Metabolism; Oxytetracycline Action Pathway; Tetracycline Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Roxithromycin Action Pathway; Purine Metabolism; Ammonia Recycling |
| PharmGKB | PA164744376 |
| ChEMBL | CHEMBL752 |
